Clal Biotechnology Industries Ltd

NEW
XTAE:CBI (Israel)  
₪ 0.24 (0%) Aug 12
At Loss
P/B:
1.86
Market Cap:
₪ 37.64M ($ 12.71M)
Enterprise V:
₪ 56.39M ($ 19.03M)
Volume:
81.90K
Avg Vol (2M):
75.07K
Trade In:
Volume:
81.90K
At Loss

Business Description

Description
Clal Biotechnology Industries Ltd is a life sciences investment company. The company invests in companies ranging from seed to maturity, both public and private. Its portfolio of investments includes from heavy industry to biotechnology, hi-tech and energy companies.
Name Current Vs Industry Vs History
Cash-To-Debt
0.1
Equity-to-Asset
0.48
Debt-to-Equity
0.88
Debt-to-EBITDA
-0.9
Piotroski F-Score
3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate
-0.3
3-Year EPS without NRI Growth Rate
32.7
3-Year FCF Growth Rate
59.8
3-Year Book Growth Rate
-45.7
Name Current Vs Industry Vs History
5-Day RSI
22.13
9-Day RSI
28.23
14-Day RSI
33.25
3-1 Month Momentum %
-20.23
6-1 Month Momentum %
-15.79
12-1 Month Momentum %
-13.92

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
0.14
Quick Ratio
0.14
Cash Ratio
0.1

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield %
9.78
Name Current Vs Industry Vs History
ROE %
-49.52
ROA %
-24.72
ROIC %
-6.93
3-Year ROIIC %
-6.85
ROC (Joel Greenblatt) %
-1397.33
ROCE %
-56.72
Years of Profitability over Past 10-Year
1
Name Current Vs Industry Vs History
PB Ratio
1.86
Price-to-Tangible-Book
1.85
EV-to-EBIT
-2.81
EV-to-EBITDA
-2.84
EV-to-FCF
-14.47
Earnings Yield (Greenblatt) %
-35.57
FCF Yield %
-10.49

Financials

XTAE:CBI's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

Clal Biotechnology Industries Ltd Executives

Details

GF Valueâ„¢

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil ₪)
EPS (TTM) (₪) -0.09
Beta 0.4326
3-Year Sharpe Ratio -0.46
3-Year Sortino Ratio -0.65
Volatility % 45.25
14-Day RSI 33.25
14-Day ATR (₪) 0.009665
20-Day SMA (₪) 0.25655
12-1 Month Momentum % -13.92
52-Week Range (₪) 0.237 - 0.44
Shares Outstanding (Mil) 156.85

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Clal Biotechnology Industries Ltd Filings

Filing Date Document Date Form
No Filing Data

Clal Biotechnology Industries Ltd Stock Events

Financials Calendars
Event Date Price (₪)
No Event Data

Clal Biotechnology Industries Ltd Frequently Asked Questions

What is Clal Biotechnology Industries Ltd(XTAE:CBI)'s stock price today?
The current price of XTAE:CBI is ₪0.24. The 52 week high of XTAE:CBI is ₪0.44 and 52 week low is ₪0.24.
When is next earnings date of Clal Biotechnology Industries Ltd(XTAE:CBI)?
The next earnings date of Clal Biotechnology Industries Ltd(XTAE:CBI) is .
Does Clal Biotechnology Industries Ltd(XTAE:CBI) pay dividends? If so, how much?
Clal Biotechnology Industries Ltd(XTAE:CBI) does not pay dividend.

Press Release

Subject Date
No Press Release

Articles on Clal Biotechnology Industries Ltd

No articles.